Websites, domains, hosts that links to products.sanofi.us
Our database shows, that the website products.sanofi.us is linked by a total of 21 websites.
Number of websites/domains displayed: 21
Results found: 21
Websites discovered:
MULTAQ (dronedarone) 400mg tablets Official Sitehttp://pageoverview.com/website-report/multaq.com
MULTAQ is the only prescription medicine of its kind that can help lower your chance of going into the hospital for atrial fibrillation (AFib). Learn more here.
- Expected expiration: March 28th in 2018
- Creation date: March 28th in 2001
- Renew date: March 24th in 2016
Jevtana® (cabazitaxel) Injection | Advanced Prostate Cancerhttp://pageoverview.com/website-report/jevtana.com
Jevtana® (cabazitaxel) Injection is indicated for treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen.
- Expected expiration: July 23rd in 2018
- Creation date: July 23rd in 2002
- Renew date: July 19th in 2016
AUBAGIO®: Once-Daily Relapsing Multiple Sclerosis Treatment| RRMShttp://pageoverview.com/website-report/aubagio.com
AUBAGIO® (teriflunomide) is a once-daily prescription medicine for relapsing remitting multiple sclerosis (RRMS) treatment. Read full safety info.
- Expected expiration: September 15th in 2018
- Creation date: September 15th in 2010
- Renew date: September 11th in 2016
Lantus® (insulin glargine injection) 100 Units/mLhttp://pageoverview.com/website-report/lantus.com
Learn more about long-acting Lantus® (insulin glargine injection) 100 Units/mL and find ways to help manage diabetes.
- Expected expiration: August 2nd in 2018
- Creation date: August 3rd in 1998
- Renew date: July 29th in 2016
Relapsing MS Infusion Treatment | LEMTRADA® (alemtuzumab)http://pageoverview.com/website-report/lemtrada.com
LEMTRADA®, because of its risks, is generally for relapsing MS patients who have tried 2 or more MS medicines that didn't work well enough.
- Expected expiration: December 29th in 2018
- Creation date: December 29th in 2010
- Renew date: December 25th in 2016
SOLIQUA® 100/33 | Official Patient Websitehttp://pageoverview.com/website-report/soliqua100-33.com
SOLIQUA® 100/33 (insulin glargine & lixisenatide injection) 100 UnitsmL & 33 mcg/mL is for adults with type 2 diabetes.
- Expected expiration: September 14th in 2018
- Creation date: September 14th in 2016
- Renew date: September 14th in 2016
Osteoarthritis Knee Pain Relief | Synvisc-One® For HCPshttp://pageoverview.com/website-report/synvisconehcp.com
Get information about the Synvisc-One injection. Help your patients relieve osteoarthritis knee pain for up to six months. Sign up to stay informed.
- Expected expiration: March 1st in 2018
- Creation date: March 1st in 2012
- Renew date: February 26th in 2016
- Google Analytics: 7433141-21
Toujeo® (insulin glargine injection) 300 Units/mLhttp://pageoverview.com/website-report/toujeo.com
Learn about Toujeo® (insulin glargine injection) 300 Units/mL, a long-acting insulin for adults with diabetes that may help with blood sugar control.
- Expected expiration: November 12th in 2018
- Creation date: November 12th in 2013
- Renew date: November 8th in 2016
KEVZARA® (sarilumab)http://pageoverview.com/website-report/kevzara.com
KEVZARA® (sarilumab) is now available for adults with moderately to severely active rheumatoid arthritis. Learn about dosing, safety info, and side effects here.
- Expected expiration: October 6th in 2018
- Creation date: October 6th in 2014
- Renew date: October 2nd in 2016
LOVENOX®-: Treatment for Deep Vein Thrombosis (DVT) Blood Clotshttp://pageoverview.com/website-report/lovenox.com
LOVENOX® is an anticoagulant therapy indicated to help reduce the risk of developing DVT, or deep vein thrombosis, which may lead to pulmonary embolism (PE)
- Expected expiration: January 22nd in 2019
- Creation date: January 22nd in 2000
- Renew date: January 4th in 2017
PRALUENT® (alirocumab) Injection | Official Sitehttp://pageoverview.com/website-report/praluent.com
Discover PRALUENT® (alirocumab) for adults with uncontrolled bad cholesterol who have heart problems due to plaque build-up in arteries or HeFH.
- Expected expiration: April 25th in 2018
- Creation date: April 25th in 2014
- Renew date: April 21st in 2016
RenValuehttp://pageoverview.com/website-report/renvalue.com
- Expected expiration: September 21st in 2018
- Creation date: September 21st in 2009
- Renew date: September 17th in 2016
- Google Analytics: 18523189-1
Lantus® (insulin glargine injection) 100 Units/mLhttp://pageoverview.com/website-report/getbloodsugarcontrol.com
Learn more about long-acting Lantus® (insulin glargine injection) 100 Units/mL and find ways to help manage diabetes.
- Expected expiration: September 15th in 2018
- Creation date: September 15th in 2011
- Renew date: September 11th in 2016
Patients and Caregivershttp://pageoverview.com/website-report/leukine.com
Leukine® (sargramostim) is contraindicated in patients with excessive leukemic myeloid blasts in bone marrow or peripheral blood (≥ 10%), in patients with known hypersensitivity to GM-CSF, yeast derived products or any components of Leukine, and for concomitant use with chemotherapy and radiotherapy. Please see Full Prescribing Information.
- Expected expiration: September 29th in 2018
- Creation date: September 30th in 1998
- Renew date: September 25th in 2016
- Google Analytics: 7433141-25
Sanofi Patient Connection Onlinehttp://pageoverview.com/website-report/visitspconline.com
- Expected expiration: December 5th in 2017
- Creation date: December 5th in 2011
- Renew date: December 1st in 2016
Regeneron Pharmaceuticals | Delivering life-transforming medicineshttp://pageoverview.com/website-report/regeneron.com
Regeneron (NASDAQ: REGN) is a leading biotechnology company using the power of science to bring new medicines to patients in need.
- Expected expiration: July 9th in 2023
- Creation date: July 10th in 1997
- Renew date: February 20th in 2017
- Google Analytics: 4731979-2
PRALUENT® (alirocumab) for Health Care Professionalshttp://pageoverview.com/website-report/praluenthcp.com
Find Health Care Professional focused information about PRALUENT® (alirocumab), for patients with poorly controlled LDL-C and HeFH or clinical ASCVD.
- Expected expiration: June 4th in 2018
- Creation date: June 4th in 2015
- Renew date: May 31st in 2017
Toujeo® (insulin glargine injection) 300 Units/mL HCP Sitehttp://pageoverview.com/website-report/toujeopro.com
Learn about Toujeo® (insulin glargine injection) 300 Units/mL, a basal insulin indicated to improve glycemic control in adult patients with diabetes.
- Expected expiration: June 23rd in 2018
- Creation date: June 23rd in 2014
- Renew date: June 19th in 2016
Thymoglobulin [Anti-thymocyte Globulin (Rabbit)] | Official Websitehttp://pageoverview.com/website-report/thymoglobulin.com
Thymoglobulin [Anti-thymocyte Globulin (Rabbit)] for kidney transplant immunosuppression. Learn about risk factors to consider during a kidney transplant.
- Expected expiration: June 4th in 2018
- Creation date: June 4th in 2003
- Renew date: May 31st in 2016